In ciliates, sex often renews and reorganizes nuclei without immediately increasing cell number, and its outcomes depend on both germline DNA and the old somatic nucleus. nuclear dimorphism is central. A usually diploid micronucleus preserves the germline genome, while a transcriptionally active, often highly polyploid macronucleus controls vegetative cell function. Repeated binary fission can increase cell number without a sexual event; mitotic micronuclear inheritance and often amitotic macronuclear division maintain the two nuclear systems differently. Sex is therefore separable from routine population growth, although some species or strains undergo clonal ageing and benefit from, or eventually require, nuclear renewal for continued vigorous growth.

In the standard conjugation sequence of Tetrahymena thermophila, appropriately mature, compatible cells pair under suitable conditions, often starvation. The micronucleus undergoes meiosis; selected haploid products give stationary and migratory pronuclei after an additional division. Partners exchange migratory pronuclei, and each fuses its incoming and stationary pronucleus to establish a diploid zygotic nucleus. Postzygotic divisions generate new micronuclear and macronuclear lineages, while the old macronucleus is eliminated. The immediate products are two reorganized exconjugant cells, rather than a new single cell created by fusion of the entire parents. Details and product numbers vary across ciliates, so this sequence should not be imposed unchanged on every species.

Compatibility is also more varied than a male/female distinction. Tetrahymena thermophila has seven mating types, with compatibility between different types rather than differentiated sperm and eggs. Mating type is established during formation of the new somatic genome by gene-segment joining and deletion at the mating-type locus; the germline retains genetic potential not all expressed together in the macronucleus. The available outcomes are constrained by the inherited mating-type allele. Primary experiments connecting somatic rearrangements to mating-type expression demonstrate why a simple two-sex Mendelian account is inadequate.^[ref]

Some Paramecium undergo autogamy, in which meiosis and fusion of pronuclei derived from one cell renew the nuclear apparatus without a partner. This can generate pronounced homozygosity rather than introduce new alleles through outcrossing. The potential benefits of recombination and nuclear renewal must therefore be distinguished from the acquisition of genetic diversity from another individual. Sex is not invariably equivalent to outbreeding.

Formation of the new macronucleus also involves DNA elimination, amplification and extensive genome reorganization. Maternal somatic information can influence which sequences survive. In Paramecium tetraurelia, small-RNA-guided excision of the mtA promoter contributes to mating-type inheritance: the old macronuclear state can guide development of the new one.^[ref] This is an experimentally defined epigenetic pathway, not evidence that all acquired traits become heritable. After conjugation, exconjugants can share a newly combined micronuclear genotype yet develop distinct somatic states; later macronuclear assortment can further alter phenotype. Ciliate sex combines meiotic inheritance with somatic-genome reconstruction, and can serve nuclear renewal without immediate numerical reproduction or obligatory outcrossing.

The proton current supplies energy, while a conformational switch changes how that current is coupled to rotor motion. Reversing torque therefore does not require reversing the electrochemical gradient. In the proton-driven bacterial flagellar motor of Escherichia coli, the cell maintains a proton-motive force that favours proton entry. MotA and MotB form stator units anchored to the cell envelope. Proton-dependent conformational cycles of those units exert force on the rotor, including interactions with FliG.

The rotor's switch complex includes FliG, FliM and FliN. Cooperative changes in its organization alter the relative geometry of rotor and stator contacts and hence the direction in which the energy-driven cycle produces angular displacement. Structural work on the torque ring supported a mechanism in which reorientation of interacting regions changes the sign of torque.^[ref] Such structural models constrain the explanation, but should not be treated as a complete direct movie of every proton-transfer and mechanical step. The central distinction is robust: the sign of mechanical rotation changes through the motor's coupling state, while the thermodynamically favourable direction of proton flow remains inward.

This is consistent with energy conservation. With a fixed electrochemical difference, inward proton movement has a negative free-energy change. In either rotational state, the magnitude of that input can supply positive work against a resisting load. Both torque and angular displacement reverse when the motor reverses, leaving their product, the work delivered during motion against that load, positive. No principle requires a given sign of proton flow to correspond to one immutable sign of angular displacement when the protein coupling apparatus can change conformation.

Chemotaxis controls the switch bias. Receptor complexes regulate CheA, which transfers phosphoryl groups to CheY. Phosphorylated CheY binds the switch, particularly FliM-associated sites, increasing clockwise bias in the familiar E. coli swimming system. Counterclockwise rotation promotes a coherent flagellar bundle and a run; clockwise episodes disrupt the bundle and permit reorientation. An attractant response commonly reduces CheA activity and CheY phosphorylation, extending runs, while adaptation restores sensitivity. CheY phosphorylation is a regulatory signal; it does not provide the motor's main mechanical energy or reverse the proton gradient. Other bacteria can use different motor arrangements or sodium-driven stators, so this account should not be universalized to all species.

Experimentally, a tethered-cell or attached-bead assay resolves individual motor direction changes while external pH and membrane potential are controlled. Reversal without a measured reversal of the gradient supports switching of coupling. A protonophore should suppress energy supply and rotation, rather than reliably command the opposite direction. CheY perturbations and switch mutations can alter directional bias while leaving ion-driven torque generation intact. Simultaneous gradient measurements, motor speed and direction distinguish an energy deficit from a switch defect; a population swimming assay alone cannot do so. Directional control and energetic drive are separable functions of the same molecular machine.

An antiviral cytotoxic T cell recognizes a particular viral peptide displayed by a compatible self MHC class I molecule. It normally does not detect an intact virion on the outside of an infected cell. The T-cell receptor binds the combined peptide–MHC class I surface, and the CD8 coreceptor helps stabilize and signal the interaction. Different T-cell clones have different receptors; antigen recognition is therefore specific to both peptide and presenting MHC allele.

Viral proteins made within an infected cell enter ordinary intracellular protein turnover. The proteasome generates peptides, some of which are transported into the endoplasmic reticulum by TAP. Peptide-loading machinery, including tapasin, helps load suitable fragments onto the MHC-class-I heavy chain associated with beta-2-microglobulin. Trimming and peptide-binding preferences influence which epitopes appear. Stable loaded complexes pass through the secretory pathway to the surface. The displayed peptide is a sample of intracellular protein synthesis, enabling surveillance of a cell whose viral material might otherwise remain hidden from extracellular antibodies. Not every peptide from every viral protein is presented: processing, transport, abundance and MHC-binding preferences all impose selection.

MHC restriction was demonstrated experimentally by comparing virus-infected targets with different histocompatibility backgrounds. Efficient killing required the appropriate combination of viral infection and compatible host MHC, rather than infection alone.^[ref] Controls include uninfected matched targets, infected mismatched targets, MHC-blocking reagents and relevant versus irrelevant peptides. Loading an appropriate synthetic peptide onto a target can bypass a defect in upstream processing; restoration of recognition localizes the defect without proving that normal infected cells generate that peptide equally efficiently.

Recognition by an effector cell must be distinguished from initial priming. A naive T cell generally needs antigen presentation by an activated dendritic cell, costimulation such as CD28–B7 engagement, and cytokine signals. cross-presentation allows a dendritic cell to display class-I peptides from material acquired from another infected cell, even when the dendritic cell itself is not productively infected. Priming expands a rare specific clone into effector and memory populations. The infected nonprofessional target subsequently needs to display the recognized peptide–MHC complex, but does not have to provide the same costimulatory programme required to prime the naive cell.

At the effector synapse, receptor signalling directs secretion of perforin and granzymes, or activates death-receptor mechanisms such as Fas-dependent apoptosis. Cytokines also restrict infection. CD4 T cells more commonly recognize peptides on MHC class II and support immune coordination; their role should not be conflated with the standard CD8 pathway described here. Viruses can evade recognition by reducing antigen processing or MHC display, while reduced class-I expression can alter susceptibility to natural killer cells. Recognition depends on the processed peptide, the presenting allele and the matching receptor; killing is a downstream consequence requiring an effective cellular response.

p53 prevents stressed or potentially dangerous cells from expanding by coordinating repair, arrest, senescence and, when appropriate, cell death. The normal p53 protein is a sequence-specific transcription factor encoded by TP53. Its low unstressed abundance is maintained partly by MDM2-dependent ubiquitination and degradation. DNA damage, oncogene-associated stress and other perturbations can stabilize and activate it through signalling that modifies p53, its regulators and their interactions. p53 also induces MDM2, forming a negative-feedback loop that allows recovery when the initiating stress resolves.

One outcome is reversible cell-cycle arrest. p53 induces p21, a cyclin-dependent-kinase inhibitor, reducing kinase activity and helping retain RB control over E2F-dependent cell-cycle entry. This gives cells time to repair damage before DNA replication or division distributes errors. A pause itself is not DNA repair: repair enzymes must still remove lesions, and the cell must reassess whether proliferation can safely resume. Time-resolved measurements of p53, p21 and cell-cycle progression therefore distinguish a protective transient response from a permanent arrest.

Severe or persistent stress can favour apoptosis. p53-dependent expression of PUMA, NOXA and BAX can shift the balance of BCL-2-family activities towards mitochondrial outer-membrane permeabilization and caspase activation. Removing a damaged cell prevents transmission of its mutations, but costs that cell to the tissue. Alternatively, cellular senescence produces a durable arrest that blocks immediate clonal expansion. The associated secretory phenotype can recruit immune responses, yet can also alter neighbouring tissue in harmful ways. Neither apoptosis nor senescence is an inevitable consequence of every increase in p53; duration, dose, cell type and survival signals shape the outcome.

p53 also coordinates aspects of metabolism, redox control and maintenance of genome integrity. These functions can support survival during manageable stress and suppress conditions that favour transformation. It would therefore be misleading to identify normal p53 solely as a death trigger or to assume that all its anticancer effects require an acute DNA-damage checkpoint. The barrier is layered: limiting mutation accumulation, preventing inappropriate proliferation, and eliminating or durably restraining cells that have acquired dangerous changes.

Genetic evidence establishes causality. Mice lacking p53 were viable in the reported experimental population but highly susceptible to spontaneous tumours, showing that loss of its normal activity can promote tumorigenesis without requiring a special oncogenic mutant protein.^[ref] The experiment does not establish that p53 has no developmental function in every genetic background. Human inherited TP53 predisposition and recurrent somatic TP53 alterations provide complementary evidence; different missense mutants can lose normal transcriptional function, inhibit remaining wild-type subunits or acquire context-dependent new activities.

To dissect the mechanism, compare matched p53-proficient, deficient and restored cells, then perturb individual targets such as p21 or apoptotic effectors. Measure damage, proliferation, survival and long-term tumour formation separately, because reduced short-term viability is not equivalent to tumour suppression. p53 is a stress-responsive governor of cell fate whose tumour-suppressive value comes from preserving safe proliferation and preventing unsafe clonal expansion.

Selective destruction makes key transitions depend on rebuilding proteins, rather than merely reversing their phosphorylation state. ubiquitin-proteasome system supplies this directionality while cyclin-dependent kinases and phosphatases provide more rapidly reversible regulation. An ubiquitin-activating enzyme uses ATP to activate ubiquitin; transfer through an ubiquitin-conjugating enzyme and recognition by an ubiquitin ligase directs substrate modification. Suitable polyubiquitin chains target proteins to the proteasome for unfolding and destruction. Substrate recognition, rather than a general increase in protein breakdown, gives temporal specificity.

At the G1/S transition, an SCF ubiquitin ligase can recognize a phosphorylated inhibitor of a cyclin-dependent kinase. In budding yeast, multisite phosphorylation of Sic1 promotes its destruction, releasing S-phase kinase activity. This links a threshold of previous kinase activity to removal of an inhibitor. Different SCF substrate receptors recognize different proteins, and phosphorylation-dependent recognition is important for many, but not every, SCF target. Destruction reinforces entry into the new state while the kinase network supplies additional feedback.

The anaphase-promoting complex controls a particularly decisive transition. Its Cdc20-associated form is restrained by the spindle checkpoint until chromosome attachment conditions permit progression. Ubiquitination and destruction of securin release separase, which cleaves the cohesin component that holds sister chromatids together. Chromatid separation cannot be undone by putting the phosphate groups back onto an intact securin molecule, because that molecule has been degraded and the cohesion linkage has been cleaved. The combination of selective proteolysis and substrate cleavage explains why a brief regulatory transition commits the cell to anaphase.

Destruction of cyclin B lowers CDK1 activity and enables mitotic exit. Nondegradable cyclin blocked inactivation of maturation-promoting activity and exit from mitosis in frog experimental systems, directly testing necessity of cyclin destruction rather than merely observing a correlation.^[ref] The Cdh1-associated anaphase-promoting complex helps keep mitotic cyclins low through late mitosis and G1, creating an interval suitable for replication licensing. In animal cells, destruction of geminin also permits Cdt1 to support licensing. Subsequent kinase activation and licensing-factor regulation help prevent rereplication before the next cycle.

The mechanism is irreversible on the timescale of the transition, not an assertion that the cell can never make cyclin or securin again. ATP-dependent ubiquitin activation and proteasomal processing occur in an open, energy-consuming system; fresh gene expression later restores substrates under a different regulatory state. Conversely, ubiquitination alone is not synonymous with degradation: chain type and context can give other signals. Tests should compare normal and degron-mutant substrates at similar expression levels, monitor actual protein loss and kinase activity, and distinguish checkpoint arrest from failure of destruction itself. Proteolysis commits the cell by removing selected regulators, while checkpoint and feedback circuits determine when that commitment occurs.

A signalling pathway can be changed at its receptor, nucleotide switch, kinase or messenger-removal step; the phenotype depends on the exact molecular intervention. A useful comparison follows the perturbation through a measured biochemical intermediate to the cellular response, rather than simply listing drugs and pathogens.

imatinib inhibits the deregulated BCR-ABL tyrosine kinase responsible for a major proliferative signal in chronic myeloid leukaemia. Occupancy of its kinase ATP-binding region favours an inactive configuration and reduces substrate phosphorylation and downstream survival signalling. Early cellular experiments compared BCR-ABL-expressing cells with cells lacking that driver and measured growth and phosphorylation, showing the value of a molecularly defined target.^[ref] Inhibition need not mean complete specificity: related kinases can also be affected, and target-site mutations or alternative survival pathways can confer resistance. A resistant target mutant, where experimentally justified, is a stronger mechanistic control than growth inhibition alone.

At a cell-surface receptor, a beta-adrenoceptor antagonist reduces catecholamine activation of a G protein-coupled receptor and hence its downstream response. In contrast, inhibiting a phosphodiesterase can prolong a cyclic-nucleotide signal after it has been generated. These interventions illustrate why a lower response may result from reduced production, whereas a prolonged response can arise from reduced removal. Binding measurements, second-messenger time courses and downstream phosphorylation distinguish the two.

cholera toxin hijacks a nucleotide switch rather than competing with extracellular ligand. Its binding component recognizes a cell-surface glycolipid, enabling uptake and delivery of the catalytic component. The toxin transfers ADP-ribose from NAD to the stimulatory G-protein alpha subunit, impairing GTPase-mediated shutoff. Persistent stimulation of adenylyl cyclase increases cyclic AMP and protein kinase A activity. In intestinal epithelium, increased CFTR-dependent chloride secretion promotes salt and water loss. Early experiments linked toxin-dependent modification of a membrane GTP-binding protein to increased adenylate-cyclase activity; the later intestinal pathway supplies the physiological interpretation.^[ref]

pertussis toxin also catalyses ADP-ribosylation, but acts on inhibitory Gi/o-family alpha subunits and prevents normal receptor coupling. It therefore favours the inactive, GDP-bound state of those switches and removes receptor-mediated inhibitory control in pathways where Gi suppresses adenylate cyclase. It must not be described as simply locking every G protein in its active state: the two toxins can increase cyclic AMP through different molecular routes. Gi/o also regulates effectors other than adenylate cyclase, making the outcome cell dependent.

Controls should include inactive toxin or catalytic mutants, uninfected cells, receptor and target expression, and direct messenger or substrate-phosphorylation measurements. Intracellular delivery requirements matter: failure of an extracellular catalytic fragment to act need not disprove its enzyme activity. Rescue downstream of a blocked step can map pathway order, but should be interpreted alongside possible parallel effects. Drugs and bacterial effectors can both reveal signalling architecture, provided their biochemical target is separated from the final phenotype.

Antennae collect photons; reaction centres convert excitation into charge separation; electron flow then generates reducing power and a proton gradient for carbon assimilation. Chlorophyll and accessory pigments in light-harvesting complexes broaden light absorption and transfer excitation towards a photosynthetic reaction centre. Excitation-energy transfer between pigments is distinct from transferring an electron along the electron-transport chain. The reaction centre couples excitation to separation of an electron from its donor, creating an oxidizing partner and a reduced acceptor before the excitation is lost as heat or fluorescence.

In the thylakoid membrane, photosystem II uses light excitation of its reaction centre to drive electron transfer to acceptors. Its oxidized donor is regenerated using electrons extracted from water by the oxygen-evolving complex, which contains a manganese–calcium cluster. Four oxidizing equivalents permit the net reactionThe protons are released on the lumenal side. Electrons pass through plastoquinone, the cytochrome b6f complex and plastocyanin to photosystem I. Plastoquinone takes up protons on reduction and contributes to their net delivery into the lumen through the cytochrome-b6f pathway. The two photosystems operate in series because excitation at one centre alone does not bridge the full energetic span from water oxidation to efficient nicotinamide adenine dinucleotide phosphate reduction.

Excitation in photosystem I enables electron transfer to ferredoxin; ferredoxin-NADP reductase generates NADPH on the stromal side. For the four electrons corresponding to one oxygen molecule, the ideal minimum is eight photochemical excitations, four at each photosystem, yielding two NADPH. Real light requirements are higher because not every absorbed photon produces productive chemistry. The proton-motive force drives ATP synthase as protons return from the lumen to the chloroplast stroma. Counterion movements often allow a large pH component to accumulate without an equally large membrane voltage. In a classical test, an imposed acid-to-base transition in isolated chloroplast material supported ATP formation in darkness, separating the gradient's role from the immediate presence of light.^[ref] Appropriate controls compare transitions that produce a transmembrane gradient with treatments that dissipate it.

In the stroma, the Calvin cycle uses ATP and NADPH to reduce fixed carbon and regenerate the carbon acceptor. RuBisCO adds carbon dioxide to ribulose bisphosphate; subsequent phosphorylation and reduction produce triose phosphate. Fixation of three carbon dioxide molecules to one net triose phosphate requires nine ATP and six NADPH in the standard accounting, with most intermediate carbon recycled to regenerate the acceptor. “Light-independent” chemistry is not physiologically independent of light: energy supply, stromal conditions and enzyme regulation coordinate it with photochemistry.

Linear electron flow need not exactly match the ATP/NADPH demand. Cyclic electron flow around photosystem I increases proton-gradient-driven ATP production without net NADPH generation or water oxidation. Excess excitation is dangerous; non-photochemical quenching, changes in antenna allocation and photosystem repair limit damage. The chloroplast combines efficient collection with regulated conversion and protection, rather than maximizing photon capture regardless of metabolic demand.

Animal cells conserve part of the free energy from nutrient oxidation in ATP and electrochemical gradients, then couple their consumption to synthesis, transport and movement. The relevant quantity is the actual Gibbs free energy change,where $Q$ is the appropriate reaction quotient, $R$ the molar gas constant and $T$ the absolute temperature. A reaction with a positive free-energy change can proceed when physically coupled to one whose negative change makes the combined process favourable. Merely placing an exergonic reaction nearby does not accomplish coupling: an enzyme, shared intermediate or molecular machine must link the processes.

Oxidation of carbohydrates and fats supplies NADH and other reducing equivalents. In the mitochondrial electron transport chain, transfer towards oxygen releases free energy. Complexes I, III and IV couple electron transfer to proton translocation from the matrix to the intermembrane space; complex II transfers electrons without directly pumping protons. The inner mitochondrial membrane retains the resulting proton-motive force. For movement of one mole of protons from outside to inside, defineHere $F$ is the Faraday constant and $\psi$ is the electrical potential. Both the relatively negative matrix potential and its relatively alkaline pH favour inward movement. An inward driving voltage of magnitude $0.18\mathrm{V}$ corresponds to approximately $17.4\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$ per mole of protons. This is an illustrative calculation, not a universal mitochondrial measurement.

Proton movement through ATP synthase drives rotation and conformational changes that couple ADP and phosphate to ATP formation. Several protons are required per ATP, and transport of phosphate and adenine nucleotides adds energetic costs; there is no universal whole-number ATP yield for every animal cell. Reconstitution of a light-driven proton pump with ATP-synthesizing machinery in lipid vesicles showed that an independently generated gradient can support ATP formation. This experiment used an artificial mixture of components, providing a mechanistic test rather than a model of animal-cell photosynthesis.^[ref] In mitochondria, respiratory inhibitors, an ATP-synthase inhibitor and a protonophore give distinct predictions for oxygen consumption, ATP production and the gradient, helping distinguish electron transfer from coupling.

ATP then supplies a mobile chemical coupling intermediate. Transfer of a phosphate group can make an otherwise unfavourable biosynthetic step favourable through a common intermediate. sodium-potassium ATPase couples ATP hydrolysis to ion pumping; sodium-dependent cotransport uses the stored gradient for secondary active transport. Myosin couples its ATPase cycle to force and displacement on actin. Substrate-level phosphorylation also generates ATP directly during glycolysis and other reactions without an obligatory respiratory gradient. ATP hydrolysis is favourable because of the free-energy difference between the full reactant and product states under cellular conditions, not because breaking a bond alone releases energy.

Conversion is never perfectly efficient: heat is produced, proton leak can bypass ATP synthase, and controlled uncoupling can favour heat production. ATP concentration and the ATP/ADP/phosphate ratio reflect a maintained nonequilibrium state. Energy transduction is therefore a chain of coupled chemical, electrical, osmotic and mechanical changes, sustained by metabolism and constrained by thermodynamics.

Location determines access to substrates, cofactors and transport routes; identical catalytic potential can therefore serve different physiological functions in different compartments. In carbohydrate metabolism, the plasma membrane, mitochondrion and endoplasmic reticulum are selective barriers, not merely containers. A soluble enzyme cannot use a metabolite efficiently if that metabolite cannot reach its compartment, while transporter abundance matters chiefly when the transporter is in the appropriate membrane.

Most glycolysis occurs in the cytosol, whereas pyruvate dehydrogenase complex and much oxidative metabolism occur in the mitochondrial matrix. Pyruvate entry therefore links cytosolic glucose breakdown to mitochondrial oxidation. Cytosolic NADH does not freely cross the inner mitochondrial membrane: the malate-aspartate shuttle and glycerol phosphate shuttle transfer reducing equivalents through different routes. Their operation affects the energetic outcome of glucose use. In gluconeogenesis, mitochondrial pyruvate carboxylase produces oxaloacetate, but oxaloacetate itself does not freely cross that membrane. Conversion into transportable intermediates, or formation of phosphoenolpyruvate in the appropriate compartment, allows carbon to reach cytosolic steps. Enzyme localization thus imposes an obligatory transport and redox problem, not just an extra reaction label.

At the final step of hepatic glucose production, the catalytic site of glucose-6-phosphatase faces the endoplasmic-reticulum lumen. Glucose-6-phosphate must reach it through the associated transport system. Hydrolysis makes free glucose available for export, whereas the phosphate ester is largely retained by membranes. Muscle can mobilize cytosolic glycogen to glucose-6-phosphate for its own glycolysis, but lacks the hepatic glucose-6-phosphatase system needed for substantial release of that carbon as free blood glucose. Tissue function therefore depends on both enzyme expression and the membrane machinery surrounding the enzyme.

Transporter traffic changes function without waiting for new protein synthesis. In resting muscle and adipose cells, much GLUT4 resides in intracellular vesicles. Insulin signalling promotes its delivery to the cell surface and increases glucose uptake; internalization subsequently reduces surface transport capacity. Classical membrane-fractionation and transport-site measurements supported redistribution from an intracellular pool to the plasma membrane.^[ref] Fractionation requires compartment markers, and surface labelling or microscopy provides an independent check: altered fraction recovery alone could otherwise mimic redistribution. Total cellular GLUT4 is not an adequate proxy for surface uptake capacity.

Polarity provides another example. In intestinal epithelial cells, apical SGLT1 uses the sodium electrochemical gradient to take up glucose, whereas basolateral GLUT2 enables exit towards the circulation. Basolateral sodium-potassium ATPase maintains the sodium gradient. Misplacing a transporter can disrupt vectorial absorption despite normal intrinsic transport activity. Glycogen-associated regulatory enzymes similarly gain access to a localized substrate pool. These examples show why localization should be tested with activity and transport measurements as well as images. Compartmentation creates direction, regulation and tissue specialization, while requiring transporters that connect the separated reactions.

Selecting tight binding to a transition-state analogue is an ingenious route to catalytic activity, but it is an indirect and incomplete selection for a useful enzyme. A catalytic antibody can be raised against a stable molecule designed to resemble a reaction's transition state. Preferential stabilization of that configuration relative to the substrate can lower the activation free energy. In an early demonstration, antibodies elicited against suitable haptens catalysed ester hydrolysis and were inhibited by the corresponding transition-state analogues.^[ref] This established a principle of molecular recognition, rather than a guarantee that any tightly bound hapten yields efficient catalysis.

A stable analogue necessarily differs from the actual fleeting transition state. Antibody maturation selects affinity for the immunizing molecule, including groups used to attach it to a carrier, rather than directly selecting rapid repeated turnover of the desired substrate. A useful catalyst must position acid/base groups, exclude or organize water, control electrostatics, traverse all reaction intermediates and release products. Binding one geometrical approximation need not optimize those steps. Strong product binding can inhibit turnover; excellent affinity can coexist with a small turnover number. A large rate enhancement over an exceptionally slow uncatalysed reaction can still give an impractically slow absolute reaction. Limited substrate scope, difficult analogue synthesis and the production or stability requirements of an antibody scaffold add practical costs.

Performance must therefore be measured as product formation over multiple turnovers, with purified protein, no-antibody and unrelated-antibody controls, and suitable checks against contaminating enzymes. Report both turnover and substrate dependence, preferably catalytic efficiency, alongside stereoselectivity, stability and achievable substrate loading. Competitive inhibition by the immunizing hapten supports involvement of the binding site, but cannot by itself exclude every alternative source of activity.

Directed evolution instead mutates a gene, expresses a library and screens or selects the actual property required. Repeated selection of subtilisin E variants for activity in an organic solvent demonstrated improvement under the intended reaction conditions without requiring a complete mechanistic prediction of every mutation.^[ref] Starting from a natural enzyme supplies a scaffold already capable of catalytic turnover. The assay can jointly select activity, selectivity or stability, although improvements are only as relevant as the assay: better expression must not be mistaken for a better purified catalyst.

Contemporary computational enzyme design can place a modelled catalytic arrangement into a protein scaffold, then use experimental screening and directed evolution to improve it. Designed Kemp eliminases illustrate the combination of mechanistic design with subsequent empirical optimization.^[ref] Rational mutagenesis and recombination can likewise focus a library on useful positions. These methods still face imperfect models and finite search capacity; they succeed by testing catalysis more directly and iterating. The question's historical premise is best read as a loss of prominence of the classical hapten-immunization strategy, rather than proof that catalytic-antibody research has universally ceased. The decisive advance is selection for the reaction and operating conditions, with binding treated as one component of performance.